Synergistic modulation of FLT3 kinase using a FLT3 inhibitor and a farnesyl transferase inhibitor

Details for Australian Patent Application No. 2006259638 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Baumann, Christian Andrew; Gaul, Michael David; Johnson, Dana L.; Tuman, Robert W.

Agent Shelston IP

Pub. Number AU-B-2006259638

PCT Pub. Number WO2006/138155

Priority 60/690,070 10.06.05 US; 60/793,320 19.04.06 US

Filing date 7 June 2006

Wipo publication date 28 December 2006

Acceptance publication date 9 December 2010

International Classifications

A61K 31/4427 (2006.01) - containing further heterocyclic ring systems

A61K 31/00 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

3 January 2008 PCT application entered the National Phase

  PCT publication WO2006/138155 Priority application(s): WO2006/138155

9 December 2010 Application Accepted

  Published as AU-B-2006259638

7 April 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006259646-Anti-hypercholesterolemic compounds

2006259636-Razor blades